2010 Pharmaceutical ARCP Decision Aid (revised 2014

ARCP Decision Aid for Pharmaceutical Medicine – August 2014
PMST Curriculum
areas *, **
PMST Year 1
PMST Year 2
PMST Year 3
PMST Year 4
% = Module Completed
% = Module Completed
% = Module Completed
% = Module Completed
Core Module (A)
(In-work)
15%
(evidence + WPBA:
PMAT, PbD, TO)
30%
(evidence + WPBA:
PMAT, PbD, TO)
75%
(evidence + WPBA:
PMAT, PbD, TO)
100%
(evidence + WPBA:
PMAT, PbD, TO)
Core Module (B)
(In-work)
15%
(evidence + WPBA:
PMAT, PbD, TO)
30%
(evidence + WPBA:
PMAT, PbD, TO)
75%
(evidence + WPBA:
PMAT, PbD, TO)
100%
(evidence + WPBA:
PMAT, PbD, TO)
0-15%
(evidence + WPBA:
PMAT, PbD, TO)
15-30%
(evidence + WPBA:
PMAT, PbD, TO)
100% if EMC
(assessment CBA)
50-75%
(evidence + WPBA:
PMAT, PbD, TO);
100% if EMC
(assessment CBA)
100%
(evidence + WPBA
PMAT, PbD, TO)
100% if EMC
( assessment CBA)
0-15%
(evidence + WPBA:
PMAT, PbD, TO)
15-30%
(evidence + WPBA:
PMAT, PbD, TO)
100% if EMC
(assessment CBA)
50-75%
(evidence + WPBA:
PMAT, PbD, TO);
100% if EMC
(assessment CBA)
100%
( evidence + WPBA:
PMAT, PbD, TO)
100% if EMC
(assessment CBA)
0-15%
(evidence + WPBA
PMAT, PbD, TO)
15-30%
(evidence + WPBA:
PMAT, PbD, TO)
100% if EMC
(assessment CBA)
50-75%
(evidence + WPBA:
PMAT, PbD, TO)
100% if EMC
(assessment CBA)
100%
(evidence + WPBA
PMAT, PbD, TO)
100% if EMC
(assessment CBA)
0-15%
(evidence + WPBA:
PMAT, PbD, TO)
15-30%
(evidence + WPBA:
PMAT, PbD, TO)
100% if EMC
(assessment CBA)
50-75%
(evidence + WPBA:
PMAT, PbD, TO)
100% if EMC
(assessment CBA)
100%
(evidence + WPBA
PMAT, PbD, TO)
100% if EMC
(assessment CBA)
0-15%
(evidence + WPBA:
PMAT, PbD, TO)
15-30%
(evidence + WPBA:
PMAT, PbD, TO, MSF)
50-75%
(evidence + WPBA:
PMAT, PbD, TO, MSF)
100%
( evidence + WPBA:
PMAT, PbD, TO)
(DPM)
(DPM)
( DPM)
(could sit Year 2, 3 & 4)
Module (C)
(In-work or Course )
Module (D)
(In-work or Course)
Module (E)
(In-work or Course)
Module (F)
(In-work or Course)
Module (G) Generic
IML
(Core; in-work)
DPM
-
* Modules A,B,C,D,E,F are from Medicines Regulation (RGN), Clinical Pharmacology (CLP), Statistics
& Data Management (SDM), Clinical Development (CLD), Healthcare Marketplace (HMP) and Drug
Safety Surveillance (DSS): two modules must be selected as core and must be completed in-work;
the remainder to be completed in- work, by module course or by a mix of in-work and courses.
Module G is the common module of Interpersonal, Management and Leadership Skills (IML): this is
core and must be completed in-work. Other key: PMAT (Pharmaceutical Medicine Assessment Tool);
MSF (Multi-Source Feedback); CBA (Course-Based Assignment), PbD (Project-based Discussion);
TO (Teaching Observation); EMC (External Module Course); WPBA (Workplace-Based Assessment).
** For In-work activities it is aimed to complete 15% after PMST Year 1, 30% after PMST Year 2,
75% after PMST Year 3 and 100% after PMST Year 4.